Search Results - "Jones, R.N."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003) by Fritsche, T.R., Stilwell, M.G., Jones, R.N.

    Published in Clinical microbiology and infection (01-12-2005)
    “…The spectrum of activity and potency of doripenem, a broad-spectrum parenteral carbapenem currently in clinical development, was evaluated using 16 008…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Evaluating sources of uncertainty in Australian runoff projections by Preston, B.L, Jones, R.N

    Published in Advances in water resources (01-05-2008)
    “…Generating estimates of the future impacts of climate change on human and natural systems is confounded by cascading uncertainties which propagate through the…”
    Get full text
    Journal Article
  10. 10

    Eight-year (2002-2009) Summary of the Linezolid (Zyvox® Annual Appraisal of potency and Spectrum; ZAAPS) Program in European Countries by Ross, J.E., Farrell, D.J., Mendes, R.E., Sader, H.S., Jones, R.N.

    Published in Journal of chemotherapy (Florence) (01-04-2011)
    “…The linezolid surveillance network (ZAAPS program) has been monitoring linezolid activity and susceptibility rates for eight years (2002-2009) in European…”
    Get full text
    Journal Article
  11. 11

    Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected in European Hospitals: Results from 7 Years of Resistance Surveillance (2003-2009) by Sader, H.S., Farrell, D.J., Jones, R.N.

    Published in Journal of chemotherapy (Florence) (01-08-2011)
    “…Daptomycin is a cyclic lipopeptide approved by the European medicines Agency (EMEA) for the treatment of complicated skin and soft tissue infections (cSSTI)…”
    Get full text
    Journal Article
  12. 12

    Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: A report from the SENTRY Antimicrobial Surveillance Program (North America) by Mathai, D., Jones, R.N., Pfaller, M.A.

    “…Bacterial urinary tract infections (UTIs) are an important cause of septicemia resulting in high mortality rates, prolonged hospital stays and increased…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    McClintock's controlling elements: the full story by Jones, R N

    Published in Cytogenetic and genome research (01-01-2005)
    “…The chapter describes the early part of Barbara McClintock's work on DNA transposons in maize, in which she uncovered the Ac-Ds family of mobile "controlling…”
    Get more information
    Journal Article
  18. 18

    The distribution of B chromosomes across species by Palestis, B G, Trivers, R, Burt, A, Jones, R N

    Published in Cytogenetic and genome research (01-01-2004)
    “…In this review we look at the broad picture of how B chromosomes are distributed across a wide range of species. We review recent studies of the factors…”
    Get more information
    Journal Article
  19. 19

    Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci by Deshpande, L.M., Jones, R.N.

    Published in Clinical microbiology and infection (01-11-2003)
    “…BAL9141 has been reported to have inhibitory activity against methicillin-resistant Staphylococcus aureus (MRSA), many enterococci, and streptococci with…”
    Get full text
    Journal Article
  20. 20

    In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents by Pfaller, M.A, Diekema, D.J, Messer, S.A, Boyken, L, Hollis, R.J, Jones, R.N

    “…We determined the in vitro susceptibilities of 643 strains of Candida spp., representing 13 species rarely isolated from blood, to ravuconazole as well as…”
    Get full text
    Journal Article